118 related articles for article (PubMed ID: 23474751)
1. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
[TBL] [Abstract][Full Text] [Related]
2. SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis.
Tang X; Shi L; Xie N; Liu Z; Qian M; Meng F; Xu Q; Zhou M; Cao X; Zhu WG; Liu B
Nat Commun; 2017 Aug; 8(1):318. PubMed ID: 28827661
[TBL] [Abstract][Full Text] [Related]
3. The F-actin bundler SWAP-70 promotes tumor metastasis.
Chang CY; Pearce G; Betaneli V; Kapustsenka T; Hosseini K; Fischer-Friedrich E; Corbeil D; Karbanová J; Taubenberger A; Dahncke B; Rauner M; Furesi G; Perner S; Rost F; Jessberger R
Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38760173
[TBL] [Abstract][Full Text] [Related]
4. Mutation of SIVA, a candidate metastasis gene identified from clonally related bilateral breast cancers, promotes breast cancer cell spread in vitro and in vivo.
Vermehren-Schmaedick A; Peto M; Wagoner W; Chiotti KE; Ramsey E; Wang X; Rakshe S; Minnier J; Sears R; Spellman P; Luoh SW
PLoS One; 2024; 19(5):e0302856. PubMed ID: 38722955
[TBL] [Abstract][Full Text] [Related]
5. Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects.
Urooj T; Wasim B; Mushtaq S; Shah SNN; Shah M
Curr Cancer Drug Targets; 2020; 20(3):168-186. PubMed ID: 31858911
[TBL] [Abstract][Full Text] [Related]
6. Asparagine bioavailability governs metastasis in a model of breast cancer.
Knott SRV; Wagenblast E; Khan S; Kim SY; Soto M; Wagner M; Turgeon MO; Fish L; Erard N; Gable AL; Maceli AR; Dickopf S; Papachristou EK; D'Santos CS; Carey LA; Wilkinson JE; Harrell JC; Perou CM; Goodarzi H; Poulogiannis G; Hannon GJ
Nature; 2018 Feb; 554(7692):378-381. PubMed ID: 29414946
[TBL] [Abstract][Full Text] [Related]
7. Context-dependent roles for ubiquitous mitochondrial creatine kinase CKMT1 in breast cancer progression.
Ayyappan V; Jenkinson NM; Tressler CM; Tan Z; Cheng M; Shen XE; Guerrero A; Sonkar K; Cai R; Adelaja O; Roy S; Meeker A; Argani P; Glunde K
Cell Rep; 2024 Apr; 43(4):114121. PubMed ID: 38615320
[TBL] [Abstract][Full Text] [Related]
8. Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs.
Steigedal TS; Toraskar J; Redvers RP; Valla M; Magnussen SN; Bofin AM; Opdahl S; Lundgren S; Eckhardt BL; Lamar JM; Doherty J; Hynes RO; Anderson RL; Svineng G
Neoplasia; 2018 Apr; 20(4):387-400. PubMed ID: 29539586
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-23b regulates cellular architecture and impairs motogenic and invasive phenotypes during cancer progression.
Pellegrino L; Krell J; Roca-Alonso L; Stebbing J; Castellano L
Bioarchitecture; 2013; 3(4):119-24. PubMed ID: 24002530
[TBL] [Abstract][Full Text] [Related]
10. ADAM12 transmembrane and secreted isoforms promote breast tumor growth: a distinct role for ADAM12-S protein in tumor metastasis.
Roy R; Rodig S; Bielenberg D; Zurakowski D; Moses MA
J Biol Chem; 2011 Jun; 286(23):20758-68. PubMed ID: 21493715
[TBL] [Abstract][Full Text] [Related]
11. Signatures of Breast Cancer Metastasis: aMENAble to Interpretation?
Oudin MJ; Gertler FB
Trends Cancer; 2017 Jan; 3(1):7-9. PubMed ID: 28718427
[TBL] [Abstract][Full Text] [Related]
12. Role of MicroRNAs in Breast Cancer Metastasis to the Brain: A New Therapeutic Perspective.
Khanegheini B; Ghasemi A; Heidari MA; Aeinfar K; Firoozi S; Tamaddon M; Fereidouni Z
Galen Med J; 2023; 12():1-4. PubMed ID: 38774849
[No Abstract] [Full Text] [Related]
13. High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation.
Dong G; Liang X; Wang D; Gao H; Wang L; Wang L; Liu J; Du Z
Med Oncol; 2014 Jul; 31(7):57. PubMed ID: 24930006
[TBL] [Abstract][Full Text] [Related]
14. IDH1 mutation produces R-2-hydroxyglutarate (R-2HG) and induces mir-182-5p expression to regulate cell cycle and tumor formation in glioma.
Zhao H; Meng L; Du P; Liao X; Mo X; Gong M; Chen J; Liao Y
Biol Res; 2024 May; 57(1):30. PubMed ID: 38760850
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 Gain-of-Function Induces Migration and Invasion through Overexpression of miR-182-5p in Cancer Cells.
Madrigal T; Ortega-Bernal D; Herrera LA; González-De la Rosa CH; Domínguez-Gómez G; Aréchaga-Ocampo E; Díaz-Chávez J
Cells; 2023 Oct; 12(20):. PubMed ID: 37887350
[TBL] [Abstract][Full Text] [Related]
16. MTSS1 curtails lung adenocarcinoma immune evasion by promoting AIP4-mediated PD-L1 monoubiquitination and lysosomal degradation.
Wang Y; Jia Z; Liang C; He Y; Cong M; Wu Q; Tian P; He D; Miao X; Sun B; Yin Y; Peng C; Yao F; Fu D; Liang Y; Zhang P; Xiong H; Hu G
Cell Discov; 2023 Feb; 9(1):20. PubMed ID: 36810288
[TBL] [Abstract][Full Text] [Related]
17. DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax.
Ye S; Xiong F; He X; Yuan Y; Li D; Ye D; Shi L; Lin Z; Zhao M; Feng S; Zhou B; Weng H; Hong L; Ye H; Gao S
Theranostics; 2023; 13(1):77-94. PubMed ID: 36593968
[No Abstract] [Full Text] [Related]
18. The Role of miRNA-182 and FOXO3 Expression in Breast Cancer.
Kandil NS; Kandil LS; Mohamed R; Selima M; El Nemr M; Barakat AR; Alwany YN
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3361-3370. PubMed ID: 36308360
[TBL] [Abstract][Full Text] [Related]
19. αvβ1 integrin is enriched in extracellular vesicles of metastatic breast cancer cells: A mechanism mediated by galectin-3.
Zhang DX; Dang XTT; Vu LT; Lim CMH; Yeo EYM; Lam BWS; Leong SM; Omar N; Putti TC; Yeh YC; Ma V; Luo JY; Cho WC; Chen G; Lee VKM; Grimson A; Le MTN
J Extracell Vesicles; 2022 Aug; 11(8):e12234. PubMed ID: 35923105
[TBL] [Abstract][Full Text] [Related]
20. MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination.
Cong M; Wang Y; Yang Y; Lian C; Zhuang X; Li X; Zhang P; Liu Y; Tang J; Yang Q; Zhang X; Xiong H; Hu R; Hu G
Nat Cancer; 2020 Feb; 1(2):222-234. PubMed ID: 35122005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
